[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.176.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 20, 1974

Correspondence

Author Affiliations

Wayne State University School of Medicine Detroit

JAMA. 1974;228(8):1040. doi:10.1001/jama.1974.03230330070037

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

Sir.—  In regard to the review of Sickle Cell Hemoglobin: Molecule to Man (227:805-806, 1974), let me take issue with Dr. Kraus's statements. He regards the text as "lucid, but rather one-sided." He has failed to recognize that the last five chapters are extensions, inferences, deductions, and clinical applications made from the Murayama hypothesis for the molecular mechanisms of sickling as discussed in the initial three chapters. I know of no other disease where such a continuous, logical linkage of concepts exists between theoretical and experimental molecular information on the one hand and analytically derived diagnostic and therapeutic gains on the other. Surely, this unique medical aspect of the book deserves at least passing acknowledgment. The book apparently appeared "one-sided" to Dr. Kraus because it is not a review of the sickle cell literature, a prodigious project; rather, the authors intended only to show in what ways the Murayama hypothesis could be used to make clinical gains.

×